DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
-0.26%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.46B
AUM Growth
+$2.46B
(+9.7%)
Cap. Flow
+$265M
Cap. Flow
% of AUM
10.77%
Top 10 Holdings %
Top 10 Hldgs %
36.93%
Holding
159
New
39
Increased
41
Reduced
16
Closed
31
Top Buys
Top Sells
| 1 |
ITMN
INTERMUNE INC
ITMN
|
$102M |
| 2 |
KERX
Keryx Biopharmaceuticals Inc
KERX
|
$36.4M |
| 3 |
ZLTQ
ZELTIQ Aesthetics, Inc.
ZLTQ
|
$23.8M |
| 4 |
HCA Healthcare
HCA
|
$21.8M |
| 5 |
AMAG
AMAG Pharmaceuticals, Inc.
AMAG
|
$20.7M |
Sector Composition
| 1 | Healthcare | 52.22% |
| 2 | Financials | 3.28% |
| 3 | Technology | 0.61% |
| 4 | Industrials | 0.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
McKesson
MCK
$85.9B
| $23.8M | 0.87% |
122,000
-28,000
| -19% | -$5.45M |
|
|
ICPT
27
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $23.4M | 0.85% |
+98,693
| New | +$23.4M |
|
28
Vanda Pharmaceuticals
VNDA
$279M
| $22.5M | 0.82% |
2,168,675
+1,083,374
| +100% | +$11.2M |
|
|
TRIV
29
DELISTED
TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
| $22.2M | 0.81% |
1,532,531
+49,865
| +3% | +$722K |
|
|
RNA
30
DELISTED
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
| $21.9M | 0.8% |
2,598,459
+392,340
| +18% | +$3.31M |
|
31
Pacific Biosciences
PACB
$378M
| $21.6M | 0.79% |
4,399,332
-295,871
| -6% | -$1.45M |
|
|
LOXO
32
DELISTED
Loxo Oncology, Inc
LOXO
| $20.9M | 0.76% |
+1,591,546
| New | +$20.9M |
|
33
Tempest Therapeutics
TPST
$46.6M
| $18.8M | 0.69% |
1,135,173
-514,276
| -31% | -$8.55M |
|
34
GSK
GSK
$79.3B
| $18.4M | 0.67% |
+400,000
| New | +$18.4M |
|
35
ANI Pharmaceuticals
ANIP
$2.06B
| $17.2M | 0.63% |
607,355
| – | – |
|
|
KERX
36
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $17M | 0.62% |
1,233,484
-2,650,925
| -68% | -$36.4M |
|
37
Orthofix Medical
OFIX
$583M
| $16.5M | 0.6% |
533,812
| – | – |
|
38
Amphastar Pharmaceuticals
AMPH
$1.37B
| $16.5M | 0.6% |
+1,415,075
| New | +$16.5M |
|
39
Cigna
CI
$80.2B
| $15.1M | 0.55% |
166,929
+9,401
| +6% | +$853K |
|
|
IMPR
40
DELISTED
IMPRIVATA, INC COM
IMPR
| $15.1M | 0.55% |
+970,951
| New | +$15.1M |
|
|
ATRS
41
DELISTED
Antares Pharma, Inc.
ATRS
| $14.3M | 0.52% |
7,823,618
-1,780,085
| -19% | -$3.26M |
|
|
SAGE
42
DELISTED
Sage Therapeutics
SAGE
| $14.2M | 0.52% |
+450,667
| New | +$14.2M |
|
|
PTLA
43
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $14.1M | 0.51% |
557,477
-27,371
| -5% | -$692K |
|
|
AET
44
DELISTED
Aetna Inc
AET
| $13.7M | 0.5% |
169,194
+344
| +0.2% | +$27.9K |
|
45
Medtronic
MDT
$118B
| $12.7M | 0.46% |
204,800
+150,000
| +274% | +$9.29M |
|
46
Trupanion
TRUP
$1.9B
| $12.4M | 0.45% |
+1,455,377
| New | +$12.4M |
|
47
Inogen
INGN
$213M
| $11.4M | 0.42% |
552,337
+25,000
| +5% | +$515K |
|
|
CMRX
48
DELISTED
Chimerix, Inc.
CMRX
| $11.2M | 0.41% |
+406,100
| New | +$11.2M |
|
|
TRNX
49
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $11.2M | 0.41% |
469,007
-270,000
| -37% | -$6.45M |
|
|
NSTG
50
DELISTED
NanoString Technologies, Inc.
NSTG
| $11M | 0.4% |
1,003,974
+549,693
| +121% | +$6.01M |
|